Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
16,463,909
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
26,299,986
-
Shares change
-
+1,509,925
-
Total reported value, excl. options
-
$965,984,248
-
Value change
-
+$58,612,650
-
Put/Call ratio
-
3.62%
-
Number of buys
-
40
-
Number of sells
-
-53
-
Price
-
$36.73
Significant Holders of RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT) as of Q4 2021
129 filings reported holding RAPT - RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q4 2021.
RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT) has 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26,299,986 shares
.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (3,947,685 shares), PERCEPTIVE ADVISORS LLC (2,927,565 shares), FMR LLC (2,248,833 shares), BlackRock Inc. (1,801,469 shares), Ponoi Management, LLC (1,599,417 shares), Column Group LLC (1,402,008 shares), WELLINGTON MANAGEMENT GROUP LLP (1,370,317 shares), STATE STREET CORP (1,243,787 shares), VANGUARD GROUP INC (1,206,352 shares), and KINGDON CAPITAL MANAGEMENT, L.L.C. (1,148,321 shares).
This table shows the top 96 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.